Nobivac Canine 1-Cv

CANINE CORONAVIRUS VACCINE

Killed Virus

FOR ANIMAL USE ONLY

IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.

THIMEROSAL FREE

Nobivac Canine 1-Cv Indications

This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine coronavirus. Duration of Immunity has not been established. To review efficacy and safety data, go to productdata.aphis.usda.gov.

Dosage and Administration

Inject one dose (1mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat dose 2 to 4 weeks later. Two doses are required for primary immunization.

Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.

Precautions

● Store at 2° - 8°C (35°-46°F).

● Do not freeze.

● Use new, non-chemically sterilized needles and syringes.

● Do not mix with other products.

● In case of human exposure, contact a physician.

Warnings

● Contains gentamicin as a preservative.

● Vaccinate only healthy, non-parasitized dogs.

● Do not vaccinate pregnant bitches.

● The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

Intervet Inc. d/b/a Merck Animal Health

Omaha, NE 68103 USA

VLN 165A/PCN 14P5.20

1 800 224-5318 (USA)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047080.7